Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19.

Alejo, Jennifer L; Mitchell, Jonathan; Chang, Amy; Chiang, Teresa P Y; Massie, Allan B; Segev, Dorry L; Makary, Martin A

Alejo, Jennifer L; Mitchell, Jonathan; Chang, Amy; Chiang, Teresa P Y; Massie, Allan B; Segev, Dorry L; Makary, Martin A.

Afiliación

Alejo JL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Mitchell J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Chang A; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Chiang TPY; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Makary MA; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

JAMA ; 327(11): 1085-1087, 2022 03 15.

Article en En | MEDLINE | ID: mdl-35113143

Asunto(s)

Anticuerpos Antivirales/sangre; COVID-19/sangre; SARS-CoV-2/inmunología; Adulto; Femenino; Humanos; Masculino; Persona de Mediana Edad; Factores de Tiempo; Estados Unidos; Vacunación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: JAMA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google